BCR/ABL 210 kD fusion protein (21-29)

Ask the supplier | View on supplier's website

BCR/ABL 210 kD fusion protein (21-29) is a 9-aa peptide. The hallmark of chronic myelogenous leukaemia (CML) is the presence of the Philadelphia chromosome and its resultant fusion message, BCR-ABL, and fusion protein, p210.

Supplier	BOC Sciences
Product #	BAT-009830
Pricing	Inquire

Feedback